Experiences and Lessons from Large-Scale and Complex HPV Vaccine Introductions

By November 2025, Gavi had supported HPV vaccination for 86 million girls worldwide. This milestone was driven, in part, by vaccine introductions and scale-up efforts in populous low- and middle-income countries (LMICs).

But what does it take to deliver HPV vaccines to adolescent girls in highly populous, large and complex countries?

Join the HPV Vaccine Acceleration Program Partners Initiative (HAPPI) Consortium for a webinar exploring the realities of large-scale HPV vaccine introductions. Hear firsthand from Ministry and other country representatives from India, Indonesia, and Nigeria as they share how they tackled complex partner coordination and logistics, population enumeration, and community trust-building at scale; and discover what their experiences can teach us about sustaining HPV vaccination programs for the future.